Search

everythinglearnresearchcommunity

for

Search:↓

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

Maintaining anticoagulation is crucial for patients with antiphospholipid syndrome.

Polycystic Ovary Syndrome (PCOS) can lead to diabetes, heart disease, cancer, and mental health problems.

Pregnancy can cause skin changes and conditions that need correct diagnosis and treatment for the health of the mother and baby.

Wedelolactone may help treat inflammation, infections, cancer, bone loss, and organ damage.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Minoxidil and finasteride treat hair loss in men, while minoxidil treats hair loss in women.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Oral spironolactone's effectiveness for adult female acne is not well-supported by strong evidence.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Some breast cancer chemotherapy can cause permanent hair loss.

Some parents have a mild form of congenital adrenal hyperplasia without symptoms, and they usually don't need treatment.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

Skin grafting is a key procedure for repairing skin defects, with the success depending on the right graft choice, donor site management, and aftercare.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

The document concludes that while there are promising methods to control CRISPR/Cas9 gene editing, more research is needed to overcome challenges related to safety and effectiveness for clinical use.

Androgens significantly affect female hair loss, and hormonal treatments may help.

COVID-19 temporarily affects male reproductive health, but sperm and testosterone levels generally return to normal after three months.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

New treatments aim to improve thin endometrium to help more couples with infertility.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.